Pluristem receives patent in Russia

Russia's Federal Service for Intellectual Property grants Pluristem Therapeutics (PSTI) patent no. 2515156 entitled "Methods of Treating Inflammatory Colon Diseases." The patent covers methods to treat ulcerative colitis (Crohn's Disease) using placenta-derived cells.

South Africa has already issued the company a patent on the process. Decisions in several other jurisdictions are pending.

From other sites
Comments (3)
  • PalmDesertRat
    , contributor
    Comments (3737) | Send Message
    that ticker is for the inverse T-Bonds.
    19 Jun 2014, 08:29 AM Reply Like
  • LostOkie51
    , contributor
    Comments (272) | Send Message
    Hello PDR,
    They may have corrected a mistake since your comment
    but PSTI is indeed the stock symbol for Pluristem.
    19 Jun 2014, 07:13 PM Reply Like
  • PalmDesertRat
    , contributor
    Comments (3737) | Send Message
    They changed it: it was orignally shown as PST
    19 Jun 2014, 07:28 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs